CHMI is founded on the idea that the transformation of healthcare depends on innovation, incentives, and information to drive impact.
The United States spends almost 20% of GDP on healthcare, yet continues to experience shorter life expectancy than other countries, exceptionally high rates of chronic illness, and inequality in access to healthcare and health outcomes.
Artificial intelligence (AI) and computation are transforming every industry, and healthcare is no exception. New technologies must be tied to the complex and high-stakes incentives that define the healthcare marketplace and their ultimate use, adoption, and impact. Economists are developing new models and a deeper understanding of the role of incentives in the healthcare ecosystem. Data science and the analytics of disparate information is the key to developing new AI tools and targeting and scaling these products to improve healthcare and health. We believe that combining these components is critical to informing the future of healthcare. With excellence in these areas, Berkeley is uniquely positioned to provide a hub for impact in AI and health.
CHMI plays a central role in technology development from the basic level of applied research through to scale and commercialization. Learn more about our research and impact.
Evolving Healthcare
CHMI is founded on the idea that the transformation of healthcare depends on innovation, incentives, and information to drive impact.
AI and computation are transforming every industry, and healthcare is no exception.